Login to Your Account

Watch this Space

Taiwan Biosimilars Industry Starting To Take Shape

By Dave Silver
Staff Writer

Wednesday, November 20, 2013

TAIPEI, Taiwan – With a number of novel biologics looking good in late-stage multisite FDA- or EMA-authorized clinical trials, Taiwan’s biopharmaceutical sector is starting to fulfill its early promise, rewarding the faith of its backers – both government and private sector – after decades of slow progress. Local production capacity is now ramping up; at least seven companies have their own manufacturing facilities and more are on the way.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription